Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administration.
Salinger, David H; Vicini, Paolo; Blough, David K; O'Donnell, Paul V; Pawlikowski, Matthew A; McCune, Jeannine S.
J Clin Pharmacol
; 50(11): 1292-300, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-20075185
Pharmacokinetics of treosulfan in pediatric patients undergoing hematopoietic stem cell transplantation.
Population pharmacokinetics of treosulfan and development of a limited sampling strategy in children prior to hematopoietic stem cell transplantation.
Evaluation of Limited Sampling Methods for Oral Busulfan Pharmacokinetic Monitoring in Adult Patients Undergoing Hematopoietic Stem Cell Transplantation.
Busulfan dosing algorithm and sampling strategy in stem cell transplantation patients.
Pediatric patients undergoing hematopoietic stem cell transplantation can greatly benefit from a novel once-daily intravenous busulfan dosing nomogram.
Thirteen years' experience of pharmacokinetic monitoring and dosing of busulfan: can the strategy be improved?
Accurately Achieving Target Busulfan Exposure in Children and Adolescents With Very Limited Sampling and the BestDose Software.
Population pharmacokinetics of intravenous busulfan in children: revised body weight-dependent NONMEM® model to optimize dosing.
Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematopoietic stem cell transplantation.
Performance of Busulfan Dosing Guidelines for Pediatric Hematopoietic Stem Cell Transplant Conditioning.